Celator Pharmaceuticals to be Added to Russell MicroCap

On Jun 27, 2014

Ewing-based Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, announced that effective at the close of the U.S. markets today the Company will be added to the Russell MicroCap Index(R) as part of Russell Investments’ annual reconstitution of its comprehensive set of U.S. and global equity indexes.

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective market-capitalization rankings and style attributes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Approximately $5.2 trillion in assets are benchmarked to Russell Indexes.

Annual reconstitution of Russell Indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000(R) Index and Russell Microcap Index.

Related Articles: